Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
2.000
-0.040 (-1.96%)
At close: Sep 2, 2025, 4:00 PM
1.970
-0.030 (-1.50%)
After-hours: Sep 2, 2025, 6:00 PM EDT
Company Description
Basel Medical Group Ltd provides healthcare services in Singapore.
The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures.
Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services.
The company was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd
| Country | Singapore |
| Founded | 2001 |
| IPO Date | Feb 25, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Yen Feng Chhoa |
Contact Details
Address: 6 Napier Road, Unit No. 02-10/11 Singapore, 258499 Singapore | |
| Phone | 65 6291 9188 |
| Website | baselmedical.com |
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 0002004489 |
| ISIN Number | VGG0864B1031 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yen Feng Chhoa M.D. | Group Chief Health Officer and Interim Chief Executive Officer |
| Keng Leong Fung | Executive Chairman of the Board |
| Jianing Lu | Group Chief Financial Officer and Director |
| Boon Chye Tan | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 21, 2025 | 6-K | Report of foreign issuer |
| Aug 13, 2025 | 6-K | Report of foreign issuer |
| Jul 18, 2025 | 6-K | Report of foreign issuer |
| Jul 2, 2025 | 6-K | Report of foreign issuer |
| Jun 26, 2025 | 6-K | Report of foreign issuer |
| Jun 18, 2025 | 6-K | Report of foreign issuer |
| Jun 3, 2025 | 6-K | Report of foreign issuer |
| May 22, 2025 | 6-K | Report of foreign issuer |
| May 16, 2025 | 6-K | Report of foreign issuer |
| Apr 30, 2025 | 6-K | Report of foreign issuer |